Homocystein and carotid atherosclerosis in chronic renal failure

M Lubomirova1, A Tzoncheva, J Petrova

  • 1Clinic of Nephrology, University Hospital Alexandrovska, Sofia, Bulgaria. Mljubomirova@yahoo.com

Hippokratia
|July 8, 2009
PubMed

Insights

Patients with chronic renal failure (CRF) show increased carotid intima-media thickness (IMT), a marker of atherosclerosis. Elevated homocysteine (Hcy) levels in CRF are associated with this thickening, highlighting a potential cardiovascular risk factor.

Area of Science:

  • Nephrology
  • Cardiology
  • Vascular Biology

Background:

  • Chronic renal failure (CRF) is linked to elevated total homocysteine (Hcy) levels.
  • Elevated Hcy is a suspected contributor to the high cardiovascular disease (CVD) risk in CRF patients.
  • Understanding risk factors for atherosclerosis in CRF is crucial for patient management.

Purpose of the Study:

  • To investigate the role of elevated Hcy and other cardiovascular risk factors in carotid atherosclerosis among CRF patients.
  • To assess the association between homocysteine levels and common carotid intima-media thickness (IMT) in CRF.

Main Methods:

  • Fifty-six hypertensive patients with CRF and 20 healthy controls were studied.
  • Common carotid intima-media thickness (IMT) was measured using B-mode ultrasound.
  • The correlation between Hcy levels, traditional atherosclerosis risk factors, and IMT was analyzed.

Main Results:

  • Hypertensive patients, including those with CRF, exhibited increased IMT compared to healthy controls.
  • Age, duration of hypertension, diabetes, and CRF were significant predictors of IMT.
  • Glomerular filtration rate (creatinine clearance) was the strongest determinant of Hcy levels.
  • A significant association was found between elevated Hcy and increased carotid IMT in CRF patients.

Conclusions:

  • Mild renal failure is associated with increased common carotid artery IMT.
  • Elevated plasma Hcy levels in CRF patients correlate with carotid intima-media thickening.
  • Homocysteine emerges as a significant factor associated with atherosclerosis in CRF.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...